Last reviewed · How we verify
NCT05823545
Assessment of Complications in Patients Who Underwent LPN According to the CCI
trial in Renal Cancer in 62 participants. Completed in 3 March 2021.
7 October 2020
Quick facts
| Lead sponsor | Samsun Liv Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 62 |
| Start date | 1 February 2020 |
| Primary completion | 7 October 2020 |
| Estimated completion | 3 March 2021 |
| Sites | 1 location across Turkey (Türkiye) |
Conditions studied
- Renal Cancer — all drugs for Renal Cancer →
- Surgery-Complications — all drugs for Surgery-Complications →
Sponsor
Samsun Liv Hospital
Who can join
Adults 18 to 80, any sex, with Renal Cancer or Surgery-Complications. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to compare the strength of the classical Clavien-Dindo classification system (CDC), which is a Likert scale analysis versus the comprehensive complication index (CCI), a new quantitative evaluation system, in patients undergoing laparoscopic partial nephrectomy (LPN).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05823545
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Renal Cancer
Currently open trials in the same condition.
- NCT07227415 — Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Antica · Phase 1, PHASE2 · recruiting
- NCT07037589 — Women With isoLated acUte cyStitis and Macroscopic Hematuria. Is Further Investigation Needed? · recruiting
- NCT06967961 — Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers · NA · recruiting
- NCT07141225 — Application of the "Off-Clamp And Sutureless" Technique in Robot-Assisted Partial Nephrectomy · NA · recruiting
- NCT07303725 — Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology · recruiting
Other Samsun Liv Hospital trials
Trials by the same sponsor.
- NCT04933604 — LPN in Patients With High-complex Renal Tumors · completed
- NCT05790746 — The Learning Curve for Retroperitoneoscopic Donor Nephrectomy · completed
- NCT04213157 — Laparoscopic Partial Nephrectomy for cT1 Tumors · completed
- NCT03893656 — Retroperitoneoscopic Donor Nephrectomy · completed
- NCT03918993 — Effects of Tadalafil on LMR and MHR in Patients With ED · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05823545 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Samsun Liv Hospital
- Last refreshed: 25 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05823545.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing